Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
Helicia Paz(Children's Hospital of Los Angeles), Nora Heisterkamp(City of Hope)
Cited by 45
Related Papers
TGFβ signaling plays a critical role in promoting alternative macrophage activation
|BMC Immunology|2012|413
B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
|Oncotarget|2015|95
Activity of the Aurora Kinase Inhibitor VX-680 against Bcr/Abl-Positive Acute Lymphoblastic Leukemias
|Molecular Cancer Therapeutics|2010|37
Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
|International Journal of Molecular Sciences|2022|9
Cell-Intrinsic and Extrinsic Effects of Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1